Kura Oncology (KURA) Skyrockets After FDA Approves KOMZIFTI for NPM1-Mutated AML
Kura Oncology (NASDAQ:KURA) is a clinical-stage biopharmaceutical company built on the vision of developing precision medicines that target…
Browsing Tag